These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 24297599)

  • 1. Physicochemical characterization of 9-aminocamptothecin in aqueous solutions.
    Rahman S; Patel D; Savva M
    AAPS PharmSciTech; 2014 Feb; 15(1):223-9. PubMed ID: 24297599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic and thermodynamic studies of 9-aminocamptothecin hydrolysis at physiological pH in the presence of human serum albumin.
    Patel D; Rahman S; Savva M
    Eur J Pharm Sci; 2013 Aug; 49(5):858-63. PubMed ID: 23791639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pH and human serum albumin on the cytotoxicity of a glucuronide prodrug of 9-aminocamptothecin.
    Prijovich ZM; Leu YL; Roffler SR
    Cancer Chemother Pharmacol; 2007 Jun; 60(1):7-17. PubMed ID: 16983566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical characterization and membrane binding properties of camptothecin.
    Selvi B; Patel S; Savva M
    J Pharm Sci; 2008 Oct; 97(10):4379-90. PubMed ID: 18300302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preformulation studies of a novel camptothecin anticancer agent, CKD-602: physicochemical characterization and hydrolytic equilibrium kinetics.
    Kim JH; Lee SK; Lim JL; Shin HJ; Hong CI
    Int J Pharm; 2002 Jun; 239(1-2):207-11. PubMed ID: 12052706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of the lactone and lactone plus carboxylate forms of 9-aminocamptothecin in human plasma by sensitive high-performance liquid chromatography with fluorescence detection.
    Loos WJ; Sparreboom A; Verweij J; Nooter K; Stoter G; Schellens JH
    J Chromatogr B Biomed Sci Appl; 1997 Jul; 694(2):435-41. PubMed ID: 9252060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicochemical characterization, solubilization, and stabilization of 9-nitrocamptothecin using pluronic block copolymers.
    Saha SC; Patel D; Rahman S; Savva M
    J Pharm Sci; 2013 Oct; 102(10):3653-65. PubMed ID: 23873658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermodynamic studies and loading of 7-ethyl-10-hydroxycamptothecin into mesoporous silica particles MCM-41 in strongly acidic solutions.
    Thakur R; Sivakumar B; Savva M
    J Phys Chem B; 2010 May; 114(17):5903-11. PubMed ID: 20380409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the active lactone form of 9-aminocamptothecin in plasma using solid-phase extraction and high-performance liquid chromatography.
    Takimoto CH; Klecker RW; Dahut WL; Yee LK; Strong JM; Allegra CJ; Grem JL
    J Chromatogr B Biomed Appl; 1994 Apr; 655(1):97-104. PubMed ID: 8061838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of the new prodrug 9-aminocamptothecin glucuronide (9ACG) in the presence of human serum albumin.
    Prijovich ZM; Leu YL; Roffler SR
    Biochem Pharmacol; 2003 Oct; 66(7):1181-7. PubMed ID: 14505797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and pharmacokinetic study evaluating the effect of food on the disposition of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite in patients with solid tumors.
    Zamboni WC; Goel S; Iqbal T; Parise RA; Strychor S; Repinski TV; Egorin MJ; Mani S
    Cancer Chemother Pharmacol; 2006 May; 57(5):631-9. PubMed ID: 16205924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I trial of the colloidal dispersion formulation of 9-amino-20(S)-camptothecin administered as a 72-hour continuous intravenous infusion.
    Eder JP; Supko JG; Lynch T; Bryant M; Vosburgh E; Shulman LN; Xu G; Kufe DW
    Clin Cancer Res; 1998 Feb; 4(2):317-24. PubMed ID: 9516917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic studies of 9-nitrocamptothecin on intermittent and continuous schedules of administration in patients with solid tumors.
    Jung LL; Ramanathan RK; Egorin MJ; Jin R; Belani CP; Potter DM; Strychor S; Trump DL; Walko C; Fakih M; Zamboni WC
    Cancer Chemother Pharmacol; 2004 Dec; 54(6):487-96. PubMed ID: 15322760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanistic studies on the aminopeptidase from Aeromonas proteolytica: a two-metal ion mechanism for peptide hydrolysis.
    Chen G; Edwards T; D'souza VM; Holz RC
    Biochemistry; 1997 Apr; 36(14):4278-86. PubMed ID: 9100023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physicochemical characterization of NPC 1161C, a novel antimalarial 8-aminoquinoline, in solution and solid state.
    Dutta AK; Stodghill SP; Wyandt CM
    AAPS PharmSciTech; 2011 Mar; 12(1):177-91. PubMed ID: 21191676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equilibrium kinetics of the new experimental anti-tumour compound SK&F 104864-A in aqueous solution.
    Underberg WJ; Goossen RM; Smith BR; Beijnen JH
    J Pharm Biomed Anal; 1990; 8(8-12):681-3. PubMed ID: 2100606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-performance liquid chromatographic analysis of the investigational anticancer drug 9-aminocamptothecin, as the lactone form and as the total of the lactone and the hydroxycarboxylate forms, in micro-volumes of human plasma.
    van Gijn R; Herben VM; Hillebrand MJ; ten Bokkel Huinink WW; Bult A; Beijnen JH
    J Pharm Biomed Anal; 1998 Sep; 17(8):1257-65. PubMed ID: 9800645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel camptothecin derivative incorporated in nano-carrier induced distinguished improvement in solubility, stability and anti-tumor activity both in vitro and in vivo.
    Han M; He CX; Fang QL; Yang XC; Diao YY; Xu DH; He QJ; Hu YZ; Liang WQ; Yang B; Gao JQ
    Pharm Res; 2009 Apr; 26(4):926-35. PubMed ID: 19048358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preformulation study of methazolamide for topical ophthalmic delivery: physicochemical properties and degradation kinetics in aqueous solutions.
    Jiang S; Wang F; Zhu S; Zhang X; Guo Z; Li R; Xu Q
    Int J Pharm; 2013 May; 448(2):390-3. PubMed ID: 23541985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mechanistic and kinetic study of the beta-lactone hydrolysis of Salinosporamide A (NPI-0052), a novel proteasome inhibitor.
    Denora N; Potts BC; Stella VJ
    J Pharm Sci; 2007 Aug; 96(8):2037-47. PubMed ID: 17554770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.